The French government has officially enacted a stringent regulatory framework aimed at curbing the unchecked expansion of aesthetic medicine, introducing mandatory professional requirements and a restrictive cap on the amount of time practitioners can dedicate to non-reimbursable cosmetic procedures. Published in the Journal Officiel on November 14, the decree represents a significant shift in health policy, reflecting a broader governmental effort to reconcile the booming demand for aesthetic enhancements with the urgent need to maintain access to essential medical care.

Under the new regulations, which came into force on November 15, physicians seeking to offer aesthetic treatments must satisfy two primary conditions: they must have completed five years of full-time professional experience within their primary medical specialty and must obtain a specific, state-sanctioned certification. By formalizing the path to authorization, the Ministry of Health, led by Stéphanie Rist, aims to professionalize a sector that has historically operated under a fragmented and loosely regulated environment.

A Chronology of Regulatory Reform

The move follows years of mounting pressure from health authorities, the National Order of Physicians (CNOM), and patient advocacy groups concerned about the rise of unauthorized practitioners, commonly referred to as "fake injectors." The timeline leading to this decree highlights a persistent effort to address these systemic issues:

  • 2022–2023: The CNOM reports a significant increase in complaints regarding unlicensed cosmetic procedures, documenting over 280 formal alerts. Approximately 80 of these cases were severe enough to be referred to the public prosecutor’s office for the illegal practice of medicine.
  • Early 2024: The Ministry of Health signals an intent to review the oversight of private medical practices, noting that aesthetic medicine, while highly lucrative, was increasingly drawing physicians away from public health priorities.
  • November 14, 2026: The official decree is published, establishing the 30% activity cap and the mandatory five-year experience threshold.
  • November 15, 2026: Official entry into force of the new legal framework.
  • July 1, 2027: The deadline for existing practitioners to file for the new, formal authorization of complementary exercise.
  • December 31, 2031: The final deadline for practitioners to fully comply with the 30% activity quota.

The 30% Rule: Balancing Profit and Public Health

The most controversial element of the new decree is the imposition of a 30% ceiling on aesthetic activity. This means that at least 70% of a doctor’s total practice must be dedicated to their primary specialty—whether that is general medicine, dermatology, or another field. The policy applies to all practitioners, whether they operate in the private sector, as employees, or are contracted with the national health insurance system.

The government’s rationale is rooted in the "preservation of medical time." As France grapples with "medical deserts"—geographic areas with acute shortages of primary care doctors—the Ministry of Health views the migration of physicians into the lucrative aesthetic market as a drain on national resources. By limiting the time spent on Botox, fillers, and laser treatments, the state hopes to nudge practitioners back into the essential care loop.

For those already established in the industry, the transition will be gradual. Practitioners who have operated exclusively in aesthetic medicine for more than five years are granted a transition period: they must reduce their aesthetic caseload to 50% by the end of 2026, and further down to the 30% threshold by the end of 2031.

Official Responses and Industry Backlash

The reaction to the decree has been sharply divided. The National Order of Physicians has emerged as a staunch supporter, framing the policy as a landmark victory for patient safety. In a statement released shortly after the publication of the decree, the Order characterized the measures as a necessary defense against the "degradation of medical ethics" and the rising tide of clandestine aesthetic services.

Conversely, professional representative bodies have criticized the measure as an "arbitrary and destructive" intervention. Sophie Bauer, president of the Syndicat des médecins libéraux (SML), and Dominique Bellecour, representing the union’s aesthetic medicine division, have warned that the decree could have unintended consequences.

"Under the guise of health security, the government is essentially orchestrating the disappearance of high-quality aesthetic medicine performed by trained physicians," the SML stated. Their primary argument is that the cap will not magically increase the number of general practitioner consultations, nor will it address the root causes of limited access to care. Instead, they fear the regulation will create a vacuum, driving patients toward the very "fake injectors" the government is trying to stop.

Addressing the Rise of the "Fake Injector"

The decree is part of a larger, multi-pronged effort to combat the illegal practice of medicine. The phenomenon of "fake injectors"—individuals with no medical qualifications performing invasive procedures—has become a public health hazard in recent years. These unregulated actors often operate via social media platforms, targeting vulnerable populations with low-cost treatments that carry significant risks, including tissue necrosis, blindness, and severe systemic infections.

The Ministry of Health has promised that before the end of the year, a new set of inter-ministerial actions will be launched to target these clandestine networks. This will involve increased cooperation between the Regional Health Agencies (ARS), law enforcement, and tax authorities to identify and prosecute those performing medical acts without the requisite credentials.

Economic and Ethical Implications

The economic landscape of the aesthetic medicine market in France is significant. Valued in the hundreds of millions of euros, the industry has seen double-digit annual growth over the last decade. By requiring a five-year foundational experience period, the government is effectively raising the barrier to entry, which may consolidate the market around more experienced, older practitioners while making it more difficult for younger doctors to enter the field.

From an ethical standpoint, the legislation seeks to address the "medicalization" of vanity. By enforcing a 70% commitment to core medical specialties, the government is asserting that a physician’s primary duty is to treat pathology, not merely to enhance appearance. However, critics argue that this paternalistic approach overlooks the psychological benefits of aesthetic procedures, which many patients view as essential for their mental well-being and quality of life.

Analysis: A High-Stakes Regulatory Experiment

The success of these regulations will likely be measured by two metrics: the stabilization of the aesthetic market and the impact on the availability of essential medical services. If the 30% cap results in a decline in aesthetic clinics without a corresponding increase in general medicine availability, the government may face significant political and economic pushback.

Furthermore, the enforcement mechanism will be put to the test. With the Regional Health Agencies tasked with verifying the qualifications of thousands of practitioners, the administrative burden will be immense. The potential for legal challenges from medical unions remains high, as practitioners argue that their right to exercise their profession is being unfairly curtailed.

As the implementation date of July 2027 approaches, the French healthcare system will be closely monitored. The tension between the state’s desire to regulate the medical profession for the "greater good" and the practitioners’ desire for autonomy will continue to be a central theme in the evolution of French health policy. Ultimately, the government’s gamble is that by forcing a return to traditional medical values, it can mitigate the risks of a commercialized aesthetic sector while simultaneously strengthening the backbone of the national healthcare system. Whether this policy achieves those lofty goals or simply displaces the demand to the shadows remains to be seen.

SanteNews

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.